CGTX (Cognition Therapeutics) Net Income

CGTX (cogrx.com) - company brandmark

This daily price chart for Cognition Therapeutics (CGTX) reflects the dynamics of a biopharmaceutical business that minimizes environmental impact through closed-loop water recycling and emission purification. Cognition Therapeutics (CGTX) specializes in developing innovative therapies for nervous system disorders, with the key metric standing at -0.02. However, the high cost of clinical trials is constraining profitability growth, keeping earnings at a pre-break-even level.

Net Profit: Cognition Therapeutics (CGTX) for 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for Cognition Therapeutics, Inc. (CGTX)

- stock value and consensus price forecast:
Market Price cogrx.com|CGTX - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation Cognition Therapeutics, Inc.|CGTX - Total Company Value
- company book value details:
Net Asset Value per Share Cognition Therapeutics|CGTX - Book Capitalization|Market Value to Equity Ratio cogrx.com|CGTX - Aggregate Company Assets
- debt and liquidity details:
Debt to Equity Ratio Cognition Therapeutics|CGTX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Cognition Therapeutics Inc.|CGTX - Company Total Debt|Debt to Book Capital Cognition Therapeutics, Inc.|CGTX - Company Long-Term Debts|Short-Term Debt Volume Cognition Therapeutics|Immediate Liquidity cogrx.com
- company profitability and valuation multiples indicators:
CGTX - Company Net Income
Summary company analysis:cogrx.com - CGTX
Brand item of Cognition Therapeutics, Inc.

For Cognition Therapeutics (CGTX), whose valuation depends on the success of Alzheimer's disease therapy, analyzing financial results is critically important. This metric measures the net remaining funds after deducting all operating and tax expenses. The company's current bottom-line profit stands at -0.02. This chart allows investors to filter out speculative noise from actual capital management efficiency. Negative trends here signal a high dependence on external investments.

Direct competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACAD - Company Net Income|Net Profit XENE (Xenon Pharmaceuticals Inc)|Annual Net Income Viking Therapeutics Corp|SUPN - Company Net Income|CPRX (catalystpharma.com) - Company Profit|DNLI: Net Profit|HRMY - Net Financial Result|Net Income BHVN|AMLX (Amylyx Corp) - Profit After Payment of Taxes|Net Profit TRVI|Net Financial Result praxismedicines.com|Company Net Income Anavex Life Sciences Corp. AVXL|CeriBell Inc (CBLL) - Company Net Income|PRTA - Company Net Income|ALEC (Alector, Inc.) - Company Profit|ANNX (Annexon, Inc.) - Net Income|Omeros - Final Profit|Net Income NGNE|ACIU (AC Immune S.A.) - Profit After Payment of Taxes|Net Profit VYGR|NMRA (Neumora Corp) - Final Profit|Net Profit SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Company Net Income|ACOG - Company Net Income|Final Profit IKT (Inhibikase Therapeutics Inc)|SAVA: Net Profit|Assertio (ASRT) - Net Profit|Company Net Income Coya Therapeutics Inc|VistaGen Therapeutics Inc - Profit After Tax|Net Profit OVID|ABOS - Company Net Income|CervoMed Inc - Net Income|Net Profit Alterity Therapeutics Ltd. ATHE|CLNN: Net Income|PepGen Inc. - Profit After Payment of Taxes|JUNS: Net Profit|RLMD - Net Financial Result|ANVS (Annovis Bio Corp) - Net Profit|Net Income Grace Tx (GRCE)|Company Net Income Firefly Neuroscience, Inc (AIFF)|Net Financial Result anewmeds.com|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Net Income|MetaVia, Inc. - Net Profit|Annual Net Income NeurAxis Inc (NRXS)|HSDT (heliusmedical.com) - Net Income|PASG: Profit After Payment of Taxes|Net Income NEUP|Company Profit NERV (Minerva Neurosciences Inc)|Company Net Income Athira (ATHA)|Addex - Company Profit|Net Profit ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|PTIX: Net Income|KTTA - Net Profit|cortigent.com (CRGT) - Company Net Income|Avenue Therapeutics Inc - Final Profit|Company Net Income Brainstorm Cell|Company Net Income caratherapeutics.com CARA|Net Profit CHRO|Net Income eliemtx.com ELYM|Company Net Income Intra-Cellular Therapies, Inc. ITCI|Longboard (LBPH) - Company Net Income|Marinus Pharmaceuticals - Net Profit|Annual Net Income nkgenbiotech.com (NKGN)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Company Profit SAGE|SNPX (Neurotrope) - Net Profit|Trevena Inc (TRVN) - Net Financial Result|Net Income VIGL (Vigil Neuroscience)|Profit After Payment of Taxes WENA|Net Profit CERE (Cerevel Therapeutics, Inc.)